Chest pain will, of course, remain one of the key manifestations of cardiac disease; however, accuracy of disease identification would be improved if a biomarker or biomarkers for aortic ...

Ability of cardiac markers for accurate and rapid prediction of heart failure after the onset of chest pain has added boost to the <a target=_blan ...

In addition, several circulating biomarkers are useful in the diagnosis and management of heart failure. Cardiac biomarkers, specifically cardiac troponin, are essential for the identification of ...

AFICAMTEN was found to be a safe and effective treatment for symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM), ...

Request To Download Free Sample of This Strategic Report @ The Saudi Arabia Cardiac Biomarker Diagnostic Kits Market presents a dynamic landscape driven by the growing prevalence of cardiovascular ...

To address this disease burden, Abbott developed a cardiac-specific biomarker, high-sensitivity cardiac troponin I (hs-cTnI), to help doctors more accurately predict the chances of a heart attack ...

According to this new report, the global cardiac biomarkers testing market is estimated to be valued at US$ 5.7 billion in the year 2028, growing at a CAGR of 8.5% in the period 2020 to 2028. Growth ...

Biomarkers may includes antigens, DNA, mRNA, and enzymes. Cardiac biomarkers are part of the standards of care and guidelines for myocardial infarction and heart failure. Cardiac biomarkers represent ...

Proton Intelligence Inc., developing the first-ever Continuous Potassium Monitoring (CKM™) platform, today announced the ...

Abstract: Quantum-dot Linked Immuno-Detection Assay, or QLIDA-based tests are inexpensive, fast, and highly sensitive and can quantitatively detect biomarkers in a wide concentration range, and ...

In this article, the authors will focus on cardiac, neurological and inflammatory biomarkers as potential predictors of outcome after CA. Complex and multifactorial mechanisms contribute to worsen ...

Mavacamten is a cardiac myosin inhibitor already approved for treating hypertrophic cardiomyopathy (HCM) and has demonstrated ...